{"id":109,"date":"2019-09-02T12:02:11","date_gmt":"2019-09-02T12:02:11","guid":{"rendered":"https:\/\/xspraypharma.com\/?page_id=109"},"modified":"2026-05-18T07:47:38","modified_gmt":"2026-05-18T07:47:38","slug":"bolagsstamma","status":"publish","type":"page","link":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/","title":{"rendered":"Bolagsst\u00e4mma"},"content":{"rendered":"<section class=\"block document-list\">\n\t<div class=\"container-fluid\">\n\n\t\t\t\t\t<header>\n\t\t\t\t\t\t\t\t\t<h1 class=\"h1 document-list-header\">Bolagsst\u00e4mma<\/h1>\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div class=\"editor_content\">\n\t\t\t\t\t\t<p class=\"preamble\">Handlingar f\u00f6r nedladdning relaterade till bolagsst\u00e4mmor i Xspray Pharma AB (publ)<\/p>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/header>\n\t\t\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>\u00c5rlig bolagsst\u00e4mma 12 maj 2026 <\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/04\/20260409_Xspray-Pharma_PM_AGM-2026_Kallelse_Sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tKallelse till bolagsst\u00e4mma 2026\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/04\/Xspray-Pharma-AGM-2026-Formular-for-forhandsrostning-och-anmalan-SV.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tAnm\u00e4lan och f\u00f6rhandsr\u00f6stning\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/04\/Xspray-Pharma-AGM-2026-Fullmaktsformular-sv_.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullmaktsformul\u00e4r\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/04\/Xspray-Pharma-AGM-2026-Valberedningens-forslag.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tValberedningens f\u00f6rslag och motiverande yttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/04\/Ersattningsrapport-2025-Swedish-version-Xspray-Pharma.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tErs\u00e4ttningsrapport 2025\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/04\/Revisorsyttrande-enligt-8-kap.-54-\u00a7-aktiebolagslagen-2005551-Ersattningsrapport-2025_Xspray-Pharma.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tRevisors yttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/04\/Xspray-Pharma-LTIP-2026-Optionsprogram.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tLTIP 2026 Fullst\u00e4ndigt f\u00f6rslag\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/04\/LTIP-2026_Teckningsoptionsvillkor_Terms-and-Conditions_Xspray-Pharma_.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tLTIP 2026 Villkor\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/04\/Xspray-Pharma-PSU-Program-2026_Sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tIncitamentsprogram PSU 2026 Fullst\u00e4ndigt f\u00f6rslag\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/04\/Foreslagen-ny-bolagsordning-Xspray-Pharma-AB-publ.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tF\u00f6rslag till beslut om \u00e4ndring av bolagsordningen\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2026\/05\/Xspray-AGM-2026-Stammoprotokoll-sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll \u00e5rsst\u00e4mma 12 maj 2026\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>\u00c5rlig bolagsst\u00e4mma 13 maj 2025<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2025\/04\/20250410_Xspray-Pharma-AGM-2025-Kallelse-till-AGM-13-maj-2025_.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tKallelse till bolagsst\u00e4mma 2025\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2025\/04\/Xspray-AGM-2025-Formular-och-forhandsrostning-och-anmalan-sv_.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tAnm\u00e4lan och f\u00f6rhandsr\u00f6stning\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2025\/04\/Xspray-Pharma-AGM-2025-Fullmaktsformular-sv_.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullmaktsformul\u00e4r\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2025\/04\/Xspray-Pharma-AGM-2025-Valberedningens-forslag_.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tValberedningens f\u00f6rslag och motiverande yttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2025\/04\/Ersattningsrapport-2024-Xspray-Pharma-Sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tErs\u00e4ttningsrapport 2024\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2025\/04\/Revisorsyttrande_RevR_8_2024.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tRevisors yttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2025\/04\/LTIP-2025_Fullstandigt-forslag_Sv_Eng_.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tLTIP 2025 Fullst\u00e4ndigt f\u00f6rslag\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2025\/04\/LTIP-2025_Teckningsoptionsvillkor_Terms-and-Conditions_Xspray-Pharma_.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tLTIP 2025 Villkor\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2025\/05\/Xspray-Pharma-AGM-2025-Stammoprotokoll_Web.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll \u00e5rsst\u00e4mma 13 maj 2025\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>\u00c5rlig bolagsst\u00e4mma 21 maj 2024<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2024\/04\/20240418_Xspray-Pharma-AGM-2024-Kallelse-21-maj-2024.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tKallelse till bolagsst\u00e4mma \t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2024\/04\/Xspray-Pharma-AGM-2024-Fullmaktsformular-sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullmaktsformul\u00e4r\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2024\/04\/Xspray-AGM-2024-Formular-och-forhandsrostning-och-anmalan-sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tAnm\u00e4lan och f\u00f6rhandsr\u00f6stning\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2024\/04\/Xspray-Pharma-AGM-2024-Valberedningens-forslag.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tValberedningens f\u00f6rslag och motiverande yttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2024\/04\/Xspray-Pharma_Ersattningsrapport-2023-Swe.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tErs\u00e4ttningsrapport 2023\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2024\/04\/Xspray-Pharma_Ers.-Revisorsyttrande_2023.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tRevisors yttrande \t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2024\/04\/LTIP-2024_Fullstandigt-forslag_Xspray-Pharma.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tLTIP 2024 Fullst\u00e4ndigt f\u00f6rslag\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2024\/04\/LTIP-2024_Villkor_Terms-and-Conditions_Xspray-Pharma.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tLTIP 2024 Villkor\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2024\/05\/Xspray-Pharma-AGM-2024-Stammoprotokoll.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll \u00e5rsst\u00e4mma 21 maj 2024\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>Extra bolagsst\u00e4mma 25 maj 2023<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/05\/EGM-2023-Kallelse-till-extra-bolagsstamma_Sve-1.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tKallelse till extra bolagsst\u00e4mma \t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/05\/EGM-2023-Fullmaktsformular-sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullmaktsformul\u00e4r \t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/05\/EGM-2023-Anmalan-och-Forhandsrostning-sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tAnm\u00e4lan och f\u00f6rhandsr\u00f6stning \t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>\u00c5rlig bolagsst\u00e4mma 16 maj 2023<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/04\/Xspray-Pharma-AGM-2023-Kallelse-till-arsstamma-16-maj-2023.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tKallelse till bolagsst\u00e4mma 16 maj 2023\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/04\/Xspray-Pharma-AGM-2023-Fullmaktsformular-sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullmaktsformul\u00e4r\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/04\/Xspray-Pharma-AGM-2023-Formular-och-forhandsrostning-och-anmalan-sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFormul\u00e4r f\u00f6r anm\u00e4lan och f\u00f6rhandsr\u00f6stning\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/04\/Xspray-Pharma-AGM-2023-Valberedningens-yttrande-sve.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tValberedningens f\u00f6rslag och motiverande yttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/04\/Xspray-Pharma-Ersattningsrapport-2022-Swe.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tErs\u00e4ttningsrapport 2022\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/04\/LTIP-2023_Fullstandigt-forslag_Xspray-Pharma.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tLTIP 2023 Fullst\u00e4ndigt f\u00f6rslag\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/04\/LTIP-2023_Teckningsoptionsvillkor_Xspray-Pharma.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tLTIP 2023 Villkor\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/04\/Signed-Revisorsyttrande_RevR.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tRevisorsyttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2023\/05\/Xspray-AGM-2023-Stammoprotokoll_Web.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tXspray Pharma Protokoll AGM 2023 05 16\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>\u00c5rlig bolagsst\u00e4mma 19 maj 2022<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2022\/04\/Xspray-Pharma_-_AGM_2022_-_Kallelse_sv-2.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tKallelse till bolagsst\u00e4mma 19 maj 2022\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2022\/04\/Xspray-Pharma_-_AGM_2022_-_Fullmaktsformular_sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullmaktsformul\u00e4r\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2022\/04\/Xspray-Pharma_-_AGM_2022-_Formular_for_forhandsrostning_och_anmalan_sv-1.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFormul\u00e4r f\u00f6r anm\u00e4lan och f\u00f6rhandsr\u00f6stning \t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2022\/04\/valberedningens-forslag-till-styrelse-i-xspray-pharma-ab.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tValberedningens f\u00f6rslag och motiverande yttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2022\/04\/Xspray-Pharma_-_AGM_2022_-_Fullstandigt_forslag_LTI_2022_sv.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullst\u00e4ndigt f\u00f6rslag LTI 2022\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2022\/04\/Xspray-Pharma_-_AGM_2022_-_Teckningsoptionsvillkor.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tVillkor LTI 2022\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2022\/04\/Xspray-Pharma_-_AGM_2022_-_Forslag_till_beslut_om_andring_av_bolagsordningen.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tF\u00f6rslag till beslut om \u00e4ndring av bolagsordning\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2022\/06\/Xspray-Pharma-AGM-2022-Stammoprotokoll.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll \u00e5rsst\u00e4mma 20220519\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>\u00c5rlig bolagsst\u00e4mma 20 maj 2021<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2021\/07\/Xspray_-_AGM_2021_-_Kallelse_SV.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\t Kallelse till bolagsst\u00e4mma i Xspray Pharma AB (publ) \t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2021\/07\/Xspray_-_AGM_2021_-_Fullmaktsformular_SV.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullmaktsformul\u00e4r\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2021\/07\/Xspray_-_AGM_2021_-_Formular_for_forhandsrostning_och_anmalan_SV.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFormul\u00e4r f\u00f6r anm\u00e4lan och f\u00f6rhandsr\u00f6stning \t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2021\/07\/Xspray_-_AGM_2021_-_Valberedningens_yttrarande_SV.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tValberedningens yttrande \t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2021\/07\/Xspray_-_AGM_2021_-_Fullstandigt_forslag_LTIP_2021-2024_SV.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\t Fullst\u00e4ndigt f\u00f6rslag teckningsoptioner LTIP 2021 (anst\u00e4llda) \t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2021\/07\/Xspray_-_AGM_2021_-_Bilaga_B_Villkor_for_teckningsoptioner_-_LTIP_2021-2024.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tVillkor teckningsoptioner LTIP 2021 (anst\u00e4llda)\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2021\/07\/Xspray_-_AGM_2021_-_Fullstandigt_forslag_Styrelseordforande_LTIP_2021-2026_SV.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullst\u00e4ndigt f\u00f6rslag teckningsoptioner LTIP 2021 (styrelseordf\u00f6rande)\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2021\/07\/Xspray_-_AGM_2021_-_Bilaga_B_Villkor_for_teckningsoptioner_-_Styrelseordforande_LTIP_2021-2026.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tVillkor teckningsoptioner LTIP (styrelseordf\u00f6rande)\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2021\/07\/Xspray_-_AGM_2021_-_Forslag_till_beslut_om_andring_av_bolagsordningen_SVENG.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tF\u00f6rslag till beslut om \u00e4ndring av bolagsordning\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2021\/05\/Xspray-AGM-2021-Stammoprotokoll.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll \u00e5rsst\u00e4mma 20210520\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>\u00c5rlig bolagsst\u00e4mma 14 maj 2020<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/05\/Anfo\u0308rande-VD-\u00c5rst\u00e4mman-20200514.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tVD&#8217;s anf\u00f6rande vid bolagsst\u00e4mman 14 maj 2020\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/04\/Xspray-Pharma-AGM-2020-Kallelse-till-\u00e5rsst\u00e4mma_.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tKallelse till \u00e5rsst\u00e4mma i Xspray Pharma AB (publ)\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/04\/Xspray-Pharma-AGM-2020-Formul\u00e4r-f\u00f6r-f\u00f6rhandsr\u00f6stning-och-anm\u00e4lan.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFormul\u00e4r f\u00f6r anm\u00e4lan samt f\u00f6rhandsr\u00f6stning\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/04\/Xspray-Pharma-AGM-2020-Fullmaktsformul\u00e4r.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullmaktsformul\u00e4r AGM 14 maj 2020\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/04\/Xspray-Pharma-AGM-2020-Valberedningens-yttrande.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tValberedningens f\u00f6rslag och motiverade yttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/05\/Protokoll-\u00e5rsst\u00e4mma-2020.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll \u00e5rsst\u00e4mma 2020\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>Extra bolagsst\u00e4mma 26 mars 2020<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/02\/PM-20200224_Kallelse-till-extra-bolagsst\u00e4mma.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tKallelse EGM 26 mars 2020\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/03\/EGM_2020_-_Fullst\u00e4ndigt_f\u00f6rslag_LTI_2020.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tStyrelsens f\u00f6rslag till optionsprogram_LTI 2020-2023\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/03\/Villkor_teckningsoptioner_LTI-2020-2023.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tVillkor teckningsoptioner &#8211; LTIP 2020\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/02\/App-2_Styrelsens-redog\u00f6relse-enligt-14-kap.-8\u00a7-ABL.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tStyrelsens redog\u00f6relse ABL 14, 8 \u00a7\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/02\/Revisors-yttrande-14kap8\u00a7_20200223-1.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tRevisorns yttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/03\/EGM-2020-Fullmaktsformul\u00e4r.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullmaktsformul\u00e4r EGM 26 mars 2020\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2020\/03\/EGM-Protokoll-2020-03-26.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll EGM 2020 03 26\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>\u00c5rlig bolagsst\u00e4mma 23 maj 2019<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Protokoll-a\u030arssta\u0308mma-2019.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll \u00e5rsst\u00e4mma 2019\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/10\/VINGE-7532222-v13-Xspray_-_AGM_2019_-_Kallelse_swe1.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tKallelse till \u00e5rsst\u00e4mma i Xspray Pharma AB (publ)\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/VINGE-7543839-v1-Xspray_-_AGM_2019_-_Fullmaktsformula\u0308r_swe.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\t\u00c5rsst\u00e4mma 2019 \u2013 Fullmaktsformul\u00e4r\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/VINGE-7542862-v3-Xspray_-_AGM_2019_-_Valberedningens_fo\u0308rslag_och_motiverade_yttrande.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tValberedningens f\u00f6rslag och motiverade yttrande\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>Extra bolagsst\u00e4mma 28 november 2018<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Xspray-Pharma-Kallelse-EGM-2018.DOCX.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tXspray Pharma \u2013 Kallelse EGM 2018\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/XSpray-Pharma-Villkor-teckningsoptioner-2018_2021_1.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tXSpray Pharma \u2013 Villkor teckningsoptioner 2018_2021_1\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Styrelsens-redogo\u0308relse-ABL-14_8-Signerad1.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tStyrelsens redogo\u0308relse ABL 14_8 \u2013 Signerad\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Revisorns-yttrande-signerad.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tRevisorns yttrande \u2013 signerad\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/EGM-2018-Fullmaktsformula\u0308r1.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tEGM 2018 Fullmaktsformula\u0308r\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/XSpray-Pharma-protokoll-extra-bolagssta\u0308mma-utan-ro\u0308stla\u0308ngd.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll extrast\u00e4mma\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>\u00c5rlig bolagsst\u00e4mma 14 maj 2018<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Xspray-AGM-2018_Kallelse_FINAL-2018-04-11.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tKallelse till \u00e5rsst\u00e4mma i Xspray Pharma AB (publ)\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/AGM_2018-Fullmaktsformula\u0308r.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\t\u00c5rsst\u00e4mma 2018 \u2013 Fullmaktsformula\u0308r\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Protokoll-a\u030arssta\u0308mma-utan-ro\u0308stla\u0308ngd-14-maj-2018.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll \u00e5rsst\u00e4mma, 14 maj 2018\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>Extra bolagsst\u00e4mma 20 februari 2018<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Xspray-PM-kallelse-31-jan-SV.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tXspray Pharma AB (publ) Kallelse till extra bolagsst\u00e4mma den 20 februari\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/VINGE-7293071-v1-Mermaid_-_Styrelsens_redogo\u0308relse_-_EXECUTED.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tStyrelsens redog\u00f6relse enligt 13 kap. 6 \u00a7 aktiebolagslagen\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Revisorsyttrande.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tRevisorns yttrande enligt 13 kap. 6 \u00a7 aktiebolagslagen \u00f6ver styrelsens redog\u00f6relse f\u00f6r v\u00e4sentliga h\u00e4ndelser f\u00f6r perioden 2017-03-31 \u2013 2018-01-30\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/VINGE-7290037-v8-Xspray_-_EGM_2018_-_Emissionsfo\u0308rslag_Sw.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tStyrelsens f\u00f6r Xspray Pharma AB (publ) f\u00f6rslag till beslut om riktad nyemission av aktier\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/VINGE-7290041-v2-Xspray_-_EGM_2018_-_Fullmaktsformula\u0308r_Sw.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tFullmaktsformul\u00e4r\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Protokoll-extrasta\u0308mma.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tProtokoll extrasta\u0308mma\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\t\t\n\t\t\t\t<article class=\"document-section\">\n\n\t\t\t\t\t\t\t\t\t\t\t<h2>Extra bolagsst\u00e4mma 4 augusti 2017<\/h2>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<ul class=\"documents\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Xspray-Microparticles-AB-Kallelse-till-extra-bolagssta\u0308mma-den-4-augusti-....pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tXspray Microparticles AB Kallelse till extra bolagsst\u00e4mma den 4 augusti\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<i class=\"fal fa-file-pdf\"><\/i>\n\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/xspraypharma.com\/wp-content\/uploads\/2019\/11\/Styrelsens-fo\u0308rslag-till-beslut-om-a\u0308ndring-av-bolagsordningen-Punkt-7.pdf\" target=\"_blank\">\n\t\t\t\t\t\t\t\t\t\tStyrelsens f\u00f6rslag till beslut om \u00e4ndring av bolagsordningen (Punkt 7)\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t\t\t<\/article>\n\t\t\t\t\t\n\t<\/div>\n<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":87,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-109","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bolagsst\u00e4mma - Xspray<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bolagsst\u00e4mma - Xspray\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/\" \/>\n<meta property=\"og:site_name\" content=\"Xspray\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-18T07:47:38+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/\",\"url\":\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/\",\"name\":\"Bolagsst\u00e4mma - Xspray\",\"isPartOf\":{\"@id\":\"https:\/\/xspraypharma.com\/sv\/#website\"},\"datePublished\":\"2019-09-02T12:02:11+00:00\",\"dateModified\":\"2026-05-18T07:47:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/xspraypharma.com\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investerare\",\"item\":\"https:\/\/xspraypharma.com\/sv\/investerare\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Bolagsstyrning\",\"item\":\"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Bolagsst\u00e4mma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/xspraypharma.com\/sv\/#website\",\"url\":\"https:\/\/xspraypharma.com\/sv\/\",\"name\":\"Xspray\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/xspraypharma.com\/sv\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bolagsst\u00e4mma - Xspray","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/","og_locale":"sv_SE","og_type":"article","og_title":"Bolagsst\u00e4mma - Xspray","og_url":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/","og_site_name":"Xspray","article_modified_time":"2026-05-18T07:47:38+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/","url":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/","name":"Bolagsst\u00e4mma - Xspray","isPartOf":{"@id":"https:\/\/xspraypharma.com\/sv\/#website"},"datePublished":"2019-09-02T12:02:11+00:00","dateModified":"2026-05-18T07:47:38+00:00","breadcrumb":{"@id":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/bolagsstamma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/xspraypharma.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Investerare","item":"https:\/\/xspraypharma.com\/sv\/investerare\/"},{"@type":"ListItem","position":3,"name":"Bolagsstyrning","item":"https:\/\/xspraypharma.com\/sv\/investerare\/bolagsstyrning\/"},{"@type":"ListItem","position":4,"name":"Bolagsst\u00e4mma"}]},{"@type":"WebSite","@id":"https:\/\/xspraypharma.com\/sv\/#website","url":"https:\/\/xspraypharma.com\/sv\/","name":"Xspray","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xspraypharma.com\/sv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/comments?post=109"}],"version-history":[{"count":130,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/109\/revisions"}],"predecessor-version":[{"id":11411,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/109\/revisions\/11411"}],"up":[{"embeddable":true,"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/pages\/87"}],"wp:attachment":[{"href":"https:\/\/xspraypharma.com\/sv\/wp-json\/wp\/v2\/media?parent=109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}